Angela Cenci Nilsson
101 – 155 of 155
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2009
-
Mark
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.
(
- Contribution to journal › Article
-
Mark
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
(
- Contribution to journal › Article
-
Mark
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Pathophysiology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
2009) p.434-444(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Dopamine replacement therapy in Parkinson´s Disease: past, present and future
2009) p.309-334(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rodent models of treatment-induced motor complications in Parkinson's disease
(
- Contribution to journal › Article
- 2008
-
Mark
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
(
- Contribution to journal › Article
-
Mark
Two routes for L-dopa to be converted to dopamine
2008) 15th Annual Meeting of the American Society for Neural Therapy and Repair In Cell Transplantation 17(4). p.482-482(
- Contribution to journal › Published meeting abstract
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
(
- Contribution to journal › Article
-
Mark
Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model.
(
- Contribution to journal › Scientific review
-
Mark
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with l-DOPA: Relation to dose and route of administration.
(
- Contribution to journal › Article
-
Mark
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
(
- Contribution to journal › Article
-
Mark
Expression pattern of JunD after acute or chronic l-DOPA treatment: Comparison with DeltaFosB.
(
- Contribution to journal › Article
-
Mark
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Advances in understanding l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
(
- Contribution to journal › Article
-
Mark
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.
2007) In Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] Chapter 9(Oct). p.9-25(
- Contribution to journal › Article
- 2006
-
Mark
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
(
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
(
- Contribution to journal › Letter
-
Mark
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
(
- Contribution to journal › Article
-
Mark
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Mechanisms of L-DOPA-induced dyskinesia in Parkinson´s disease: What do animal models tell us?
2006) p.351-360(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Dyskinesia and neural grafting in Parkinson's disease
2006) p.184-224(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
(
- Contribution to journal › Article
-
Mark
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
(
- Contribution to journal › Article
-
Mark
Chapte B7 - Utility of 6-hydroxydopamine lesioned rats in the preclinical screening of novel treatments for Parkinson disease
2005) p.193-208(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
(
- Contribution to journal › Article
-
Mark
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)
(
- Contribution to journal › Article
-
Mark
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism
(
- Contribution to journal › Article
- 2003
-
Mark
Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.
(
- Contribution to journal › Article
-
Mark
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2002
-
Mark
L-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function.
(
- Contribution to journal › Article
-
Mark
Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Animal models of neurological deficits: how relevant is the rat?
(
- Contribution to journal › Article
- 2001
-
Mark
cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum
(
- Contribution to journal › Article
-
Mark
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2000
-
Mark
Serotonin release from mesencephalic raphe neurons grafted to the 5,7-dihydroxytryptamine-lesioned rat hippocampus : Effects of behavioral activation and stress
(
- Contribution to journal › Article
-
Mark
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 1994
-
Mark
Seizure development and noradrenaline release in kindling epilepsy after noradrenergic reinnervation of the subcortically deafferented hippocampus by superior cervical ganglion or fetal locus coeruleus grafts
(
- Contribution to journal › Article
-
Mark
Seizure development and noradrenaline release in kindling epilepsy after noradrenergic reinnervation of the subcortically deafferented hippocmapus by superior cervical ganglion or fetal locus coeruleus grafts
(
- Contribution to journal › Article
- 1993
-
Mark
Characterization of in vivo noradrenaline release from superior cervical ganglia or fetal locus coeruleus transplanted to the subcortically deafferented hippocampus in the rat
(
- Contribution to journal › Article
- 1992
-
Mark
Striatal c-fos Induction by Cocaine or Apomorphine Occurs Preferentially in Output Neurons Projecting to the Substantia Nigra in the Rat
(
- Contribution to journal › Article
- 1991
-
Mark
Host Brain Regulation of Fetal Locus Coeruleus Neurons Grafted to the Hippocampus in 6-Hydroxydopamine-Treated Rats. An Intracerebral Microdialysis Study
(
- Contribution to journal › Article
- 1990
-
Mark
Intracerebral microdialysis as a tool to monitor transmitter release from grafted cholinergic and monoaminergic neurons
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »